Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-19-023478

President and CEO sold 18,333 shares at an average $25.03 ($458,800)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-04-01 Sale : show line 1 in the form −6,050 $23.91 $144,656 2,609,921 I
2019-04-02 Sale : show line 2 in the form −3,200 $24.52 $78,464 2,606,721 I
2019-04-02 Sale : show line 3 in the form −2,942 $25.17 $74,050 2,603,779 I
2019-04-03 Sale : show line 4 in the form −5,641 $26.28 $148,245 2,598,138 I
2019-04-03 Sale : show line 5 in the form −500 $26.77 $13,385 2,597,638 I
Open-market sales · 18,333 sh · avg $25.03 · $458,800
Loading xslF345X03/doc4.xml…